Side-by-side comparison of AI visibility scores, market position, and capabilities
Designer Brands (NYSE: DBI) warehouse footwear retailer with 30M+ VIP loyalty members; competing with Foot Locker and TJ Maxx for brand-name shoe discounts as brands shift to DTC channels.
DSW (Designer Shoe Warehouse) is a specialty footwear retailer offering brand-name and designer shoes at discounted prices through a warehouse-style retail format — featuring wide selection from Nike, Steve Madden, Sam Edelman, UGG, Birkenstock, Cole Haan, and hundreds of other brands for women, men, and children, alongside accessories. DSW is owned by Designer Brands Inc. (NYSE: DBI), which also owns The Shoe Company (Canada) and Vince Camuto, generating approximately $3 billion in annual revenue across the portfolio.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.